genechip™ human genome u133 plus 2.0 microarray (Thermo Fisher)
Thermo Fisher is a verified supplier 
Thermo Fisher manufactures this product 
90
Structured Review
Thermo Fisher
genechip™ human genome u133 plus 2.0 microarray
Genechip™ Human Genome U133 Plus 2.0 Microarray, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/genechip+human+genome+u133+plus+2%2E0+microarray/pm39748408-62-19-26
Average 90 stars, based on 1 article reviews
Genechip™ Human Genome U133 Plus 2.0 Microarray, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/genechip+human+genome+u133+plus+2%2E0+microarray/pm39748408-62-19-26
Average 90 stars, based on 1 article reviews
genechip™ human genome u133 plus 2.0 microarray - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Expressing:Article Title: Silver: Forging almost Gold Standard Datasets Article Snippet: The microarray experiments were case-control experiments in humans from the Article Title: Residual risk stratification of Taiwanese breast cancers following curative therapies with the extended concurrent genes signature. Article Snippet: Introduction The aim of the study was to perform digital RNA counting to validate a gene expression signature for operable breast cancers initially treated with curative intention, and the risk of recurrence, distant metastasis, and mortality was predicted.. Methods Candidate genes were initially discovered from the coherent genomic and transcriptional alternations from microarrays, and the extended concurrent genes were used to build a risk stratification model from archived formalin-fixed paraffinembedded (FFPE) tissues with the NanoString nCounter.. Results The extended concurrent genes signature was prognostic in 144 Taiwanese breast cancers (5-year relapse-free survival: 89.8 and 69.4% for lowand high-risk group, log-rank test: P = 0.004). Article Title: HENA, heterogeneous network-based data set for Alzheimer’s disease Article Snippet: The raw .CEL files and annotations of Article Title: Gene Co-Expression Networks Restructured Gene Fusion in Rhabdomyosarcoma Cancers Article Snippet: GEO data was downloaded as robust multiarray average (RMA) normalized Article Title: Implications of publicly available genomic data resources in searching for therapeutic targets of obesity and type 2 diabetes. Article Snippet: Table 3 lists the studies on obesity or T2D with available gene expression profiles based on the Article Title: Implications of publicly available genomic data resources in searching for therapeutic targets of obesity and type 2 diabetes Article Snippet: There are many different platforms for gene expression profiling, but the most popular platform with the largest number of studies is the Article Title: Endometrial Cancer-Associated FGF18 Expression Is Reduced by Bazedoxifene in Human Endometrial Stromal Cells In Vitro and in Murine Endometrium Article Snippet: We performed a microarray using Article Title: HENA, heterogeneous network-based data set for Alzheimer’s disease Article Snippet: Co-expression in Alzheimer’s disease and healthy individuals was computed based on the selected six Microarray:Article Title: Silver: Forging almost Gold Standard Datasets Article Snippet: The microarray experiments were case-control experiments in humans from the Article Title: Residual risk stratification of Taiwanese breast cancers following curative therapies with the extended concurrent genes signature. Article Snippet: Introduction The aim of the study was to perform digital RNA counting to validate a gene expression signature for operable breast cancers initially treated with curative intention, and the risk of recurrence, distant metastasis, and mortality was predicted.. Methods Candidate genes were initially discovered from the coherent genomic and transcriptional alternations from microarrays, and the extended concurrent genes were used to build a risk stratification model from archived formalin-fixed paraffinembedded (FFPE) tissues with the NanoString nCounter.. Results The extended concurrent genes signature was prognostic in 144 Taiwanese breast cancers (5-year relapse-free survival: 89.8 and 69.4% for lowand high-risk group, log-rank test: P = 0.004). Article Title: HENA, heterogeneous network-based data set for Alzheimer’s disease Article Snippet: The raw .CEL files and annotations of Article Title: Gene Co-Expression Networks Restructured Gene Fusion in Rhabdomyosarcoma Cancers Article Snippet: GEO data was downloaded as robust multiarray average (RMA) normalized Article Title: Implications of publicly available genomic data resources in searching for therapeutic targets of obesity and type 2 diabetes. Article Snippet: Table 3 lists the studies on obesity or T2D with available gene expression profiles based on the Article Title: Implications of publicly available genomic data resources in searching for therapeutic targets of obesity and type 2 diabetes Article Snippet: There are many different platforms for gene expression profiling, but the most popular platform with the largest number of studies is the Article Title: Endometrial Cancer-Associated FGF18 Expression Is Reduced by Bazedoxifene in Human Endometrial Stromal Cells In Vitro and in Murine Endometrium Article Snippet: We performed a microarray using Article Title: HENA, heterogeneous network-based data set for Alzheimer’s disease Article Snippet: Co-expression in Alzheimer’s disease and healthy individuals was computed based on the selected six Sequencing:Article Title: Silver: Forging almost Gold Standard Datasets Article Snippet: The microarray experiments were case-control experiments in humans from the Article Title: Residual risk stratification of Taiwanese breast cancers following curative therapies with the extended concurrent genes signature. Article Snippet: Introduction The aim of the study was to perform digital RNA counting to validate a gene expression signature for operable breast cancers initially treated with curative intention, and the risk of recurrence, distant metastasis, and mortality was predicted.. Methods Candidate genes were initially discovered from the coherent genomic and transcriptional alternations from microarrays, and the extended concurrent genes were used to build a risk stratification model from archived formalin-fixed paraffinembedded (FFPE) tissues with the NanoString nCounter.. Results The extended concurrent genes signature was prognostic in 144 Taiwanese breast cancers (5-year relapse-free survival: 89.8 and 69.4% for lowand high-risk group, log-rank test: P = 0.004). Article Title: HENA, heterogeneous network-based data set for Alzheimer’s disease Article Snippet: The raw .CEL files and annotations of Article Title: Gene Co-Expression Networks Restructured Gene Fusion in Rhabdomyosarcoma Cancers Article Snippet: GEO data was downloaded as robust multiarray average (RMA) normalized Article Title: Implications of publicly available genomic data resources in searching for therapeutic targets of obesity and type 2 diabetes. Article Snippet: Table 3 lists the studies on obesity or T2D with available gene expression profiles based on the Article Title: Implications of publicly available genomic data resources in searching for therapeutic targets of obesity and type 2 diabetes Article Snippet: There are many different platforms for gene expression profiling, but the most popular platform with the largest number of studies is the Article Title: Endometrial Cancer-Associated FGF18 Expression Is Reduced by Bazedoxifene in Human Endometrial Stromal Cells In Vitro and in Murine Endometrium Article Snippet: We performed a microarray using Article Title: HENA, heterogeneous network-based data set for Alzheimer’s disease Article Snippet: Co-expression in Alzheimer’s disease and healthy individuals was computed based on the selected six Next-Generation Sequencing:Article Title: Silver: Forging almost Gold Standard Datasets Article Snippet: The microarray experiments were case-control experiments in humans from the Article Title: Residual risk stratification of Taiwanese breast cancers following curative therapies with the extended concurrent genes signature. Article Snippet: Introduction The aim of the study was to perform digital RNA counting to validate a gene expression signature for operable breast cancers initially treated with curative intention, and the risk of recurrence, distant metastasis, and mortality was predicted.. Methods Candidate genes were initially discovered from the coherent genomic and transcriptional alternations from microarrays, and the extended concurrent genes were used to build a risk stratification model from archived formalin-fixed paraffinembedded (FFPE) tissues with the NanoString nCounter.. Results The extended concurrent genes signature was prognostic in 144 Taiwanese breast cancers (5-year relapse-free survival: 89.8 and 69.4% for lowand high-risk group, log-rank test: P = 0.004). Article Title: HENA, heterogeneous network-based data set for Alzheimer’s disease Article Snippet: The raw .CEL files and annotations of Article Title: Gene Co-Expression Networks Restructured Gene Fusion in Rhabdomyosarcoma Cancers Article Snippet: GEO data was downloaded as robust multiarray average (RMA) normalized Article Title: Implications of publicly available genomic data resources in searching for therapeutic targets of obesity and type 2 diabetes. Article Snippet: Table 3 lists the studies on obesity or T2D with available gene expression profiles based on the Article Title: Implications of publicly available genomic data resources in searching for therapeutic targets of obesity and type 2 diabetes Article Snippet: There are many different platforms for gene expression profiling, but the most popular platform with the largest number of studies is the Article Title: Endometrial Cancer-Associated FGF18 Expression Is Reduced by Bazedoxifene in Human Endometrial Stromal Cells In Vitro and in Murine Endometrium Article Snippet: We performed a microarray using Article Title: HENA, heterogeneous network-based data set for Alzheimer’s disease Article Snippet: Co-expression in Alzheimer’s disease and healthy individuals was computed based on the selected six Generated:Article Title: Silver: Forging almost Gold Standard Datasets Article Snippet: The microarray experiments were case-control experiments in humans from the Article Title: Residual risk stratification of Taiwanese breast cancers following curative therapies with the extended concurrent genes signature. Article Snippet: Introduction The aim of the study was to perform digital RNA counting to validate a gene expression signature for operable breast cancers initially treated with curative intention, and the risk of recurrence, distant metastasis, and mortality was predicted.. Methods Candidate genes were initially discovered from the coherent genomic and transcriptional alternations from microarrays, and the extended concurrent genes were used to build a risk stratification model from archived formalin-fixed paraffinembedded (FFPE) tissues with the NanoString nCounter.. Results The extended concurrent genes signature was prognostic in 144 Taiwanese breast cancers (5-year relapse-free survival: 89.8 and 69.4% for lowand high-risk group, log-rank test: P = 0.004). Article Title: HENA, heterogeneous network-based data set for Alzheimer’s disease Article Snippet: The raw .CEL files and annotations of Article Title: Gene Co-Expression Networks Restructured Gene Fusion in Rhabdomyosarcoma Cancers Article Snippet: GEO data was downloaded as robust multiarray average (RMA) normalized Article Title: Implications of publicly available genomic data resources in searching for therapeutic targets of obesity and type 2 diabetes. Article Snippet: Table 3 lists the studies on obesity or T2D with available gene expression profiles based on the Article Title: Implications of publicly available genomic data resources in searching for therapeutic targets of obesity and type 2 diabetes Article Snippet: There are many different platforms for gene expression profiling, but the most popular platform with the largest number of studies is the Article Title: Endometrial Cancer-Associated FGF18 Expression Is Reduced by Bazedoxifene in Human Endometrial Stromal Cells In Vitro and in Murine Endometrium Article Snippet: We performed a microarray using Article Title: HENA, heterogeneous network-based data set for Alzheimer’s disease Article Snippet: Co-expression in Alzheimer’s disease and healthy individuals was computed based on the selected six |